Pharmacokinetics, Safety, Tolerability of TEV-48125 in Healthy Subjects After Administration of TEV-48125
- Study Title
- To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125
- Teva Identifier
- TV48125-PK-10078
- ClinicalTrials.gov Identifier
- NCT02673567
- Study Status
- Completed
- Trial Condition(s)
- Pharmacokinetics
- Interventions
- Drug: TEV-48125 - 1 | Drug: TEV-48125 - 2 | Drug: TEV-48125 - 3 | Drug: Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 55 Years
- Trial Duration
- March 31, 2016 - February 10, 2017
- Phase
- Phase 1
